(0.23%) 5 143.50 points
(0.12%) 38 489 points
(0.38%) 17 913 points
(-0.73%) $83.24
(1.61%) $1.954
(-0.15%) $2 343.70
(-0.13%) $27.50
(2.67%) $946.75
(-0.05%) $0.934
(-0.01%) $11.02
(-0.24%) $0.798
(1.90%) $93.61
Live Chart Being Loaded With Signals
XPhyto Therapeutics Corp. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder...
Stats | |
---|---|
本日の出来高 | 1 452.00 |
平均出来高 | 2 758.00 |
時価総額 | 0.00 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -2.18 |
ATR14 | €0 (0.00%) |
XPhyto Therapeutics Corp. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
XPhyto Therapeutics Corp. 財務諸表
Annual | 2021 |
収益: | €286 498 |
総利益: | €199 478 (69.63 %) |
EPS: | €-0.197 |
FY | 2021 |
収益: | €286 498 |
総利益: | €199 478 (69.63 %) |
EPS: | €-0.197 |
FY | 2020 |
収益: | €345 654 |
総利益: | €0.00 (0.00 %) |
EPS: | €-0.300 |
FY | 2019 |
収益: | €208 119 |
総利益: | €0.00 (0.00 %) |
EPS: | €-0.170 |
Financial Reports:
No articles found.
XPhyto Therapeutics Corp.
XPhyto Therapeutics Corp. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors. In addition, it offers analytical testing and consulting services; and engages in the pathogen and oral health diagnostic and screening test, thin film drug formulation, and psychedelic pharmaceutical production and formulation businesses. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。